A study to learn if bimekizumab given in different ways is safe and moves similarly throughout the body over time in adults
PA0019
Phase 1 other active
Quick answer
A study to learn if bimekizumab given in different ways is safe and moves similarly throughout the body over time in adults for CCI is a Phase 1 program (other) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- CCI
- Phase
- Phase 1
- Modality
- other
- Status
- active